Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk.

Overview
Research
Identity
Additional Document Info
View All

authors

Kalathiya, Urja N
Mickelson, Mindy M
McCoy, Rozalina G
Herrin, Jeph
Swarna, Kavya Sindu
Deng, Yihong
Polley, Eric C
Neumiller, Joshua J
Galindo, Rodolfo J
Umpierrez, Guillermo E
Joseph S. Ross, MD, MHS

publication date

September 11, 2025

published in

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists Journal

has subject area